Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection

MeSH terms

• Administration, Inhalation
• Adrenal Cortex Hormones / adverse effects
• Age Factors
• Angiotensin-Converting Enzyme Inhibitors / therapeutic use
• Anti-Bacterial Agents / therapeutic use
• Antibodies, Monoclonal, Humanized / therapeutic use
• Antiviral Agents / therapeutic use
• Azithromycin / therapeutic use
• Bromhexine / therapeutic use
• COVID-19
• Coronavirus Infections / complications
• Coronavirus Infections / drug therapy
• Coronavirus Infections / epidemiology
• Coronavirus Infections / immunology*
• Cytokines / immunology*
• Expectorants / therapeutic use
• Humans
• Hydroxychloroquine / therapeutic use
• Hypertension / epidemiology
• Inflammation
• Interferon beta-1a / immunology
• Interleukin-1 / immunology
• Interleukin-12 / immunology
• Interleukin-6 / immunology
• Lymphohistiocytosis, Hemophagocytic / etiology
• Lymphohistiocytosis, Hemophagocytic / immunology*
• Obesity / epidemiology
• Pandemics
• Pneumonia, Viral / complications
• Pneumonia, Viral / drug therapy
• Pneumonia, Viral / epidemiology
• Pneumonia, Viral / immunology*
• Pulmonary Disease, Chronic Obstructive / drug therapy
• Pulmonary Disease, Chronic Obstructive / epidemiology
• Respiratory Distress Syndrome / etiology
• Respiratory Distress Syndrome / immunology*
• Risk Factors
• Smoking / epidemiology
• Tumor Necrosis Factor-alpha / immunology